Market Access Manager, Oncology (Lung, Heamatology and GI)

Start free →

Or apply yourself on the official page →

About the role

Market Access Manager, Oncology (Lung, Heamatology and GI) Are you ready to unlock patient access to breakthrough oncology therapies and set pricing strategies that shape the market? Do you thrive at the intersection of evidence generation, affordability, and payer partnerships to deliver tangible outcomes for patients and the business? In this role, you will lead the development and execution of integrated market access strategies for the Lung, Haematology and GI portfolio in Thailand, enabling timely and sustainable patient access while delivering strategic and business value. The role is accountable for pricing, reimbursement, affordability solutions, evidence generation and payer engagement across pipeline, launch and in-market indications, in close partnership with cross-functional teams.This position will report to Market Access Lead (Oncology). Accountabilities: Pricing & Reimbursement • Own integrated access strategies, priorities, milestones, risks and mitigation plans for Lung, Haematology and GI assets across pipeline, launch and in-market indications. • Develop pricing and reimbursement strategies aligned with the brand value proposition, competitive landscape, patient needs, payer requirements and AstraZeneca governance. • Lead access planning for relevant Thailand pathways, including NLEM, NHSO, CSMBS/OCPA, CGD, SSO, hospital formulary and procurement processes. • Develop payer value propositions, reimbursement submissions, negotiation strategies and committee-engagement plans for priority products and indications. • Assess environmental, policy and competitor developments; translate implications into proactive recommendations and clear mitigation actions. • Model patient access, price, revenue, gross margin, affordability, budget impact and investment requirements under alternative access scenarios. • Design and evaluate compliant managed-entry agreements, risk-sharing arrangements, portfolio agreements and other sustainable access solutions, including governance, operational feasibility and value realization. • Lead access readiness from early asset planning through regulatory approval, launch, reimbursement and post-launch performance, including new indications and line extensions. • Serve as the Market Access lead in brand and cross-functional teams, aligning Medical, Commercial, Regulatory, Government Affairs, Finance, Legal, Compliance and regional/global partners. • Monitor access milestones, patient reach, timelines, risks and business impact, and communicate decisions required to leadership. • Drives product pricing analysis and recommendation by analyzing competitive products and pricing, ensuring alignment with brand value proposition, understanding customer groups (patients and physicians) and leading Pricing Strategy discussions • Monitors environment and practices for shifts in trends or behaviours, interprets likely impact and suggests appropriate actions • Develops deep understanding of competitive market conditions that affect pricing for individual brands and overall industry • Evaluates changing marketplace and proactively makes recommendations on pricing strategies as related to managed care, reimbursement environment, federal and state regulations • Provides modelling of pricing recommendations and financial impacts for new and existing products • Develops pricing and reimbursement strategy (including pricing bands, launch order, etc.) for existing and launch products, and maintaining over time • Determines contracting/net price strategy including risk sharing arrangements, discounting, etc • Develops and executes reimbursement support and patient assistance services to ensure patient access to products • Leads the exploration for, and evaluation of, a pipeline of potential

View the official posting →